US Patent 10098968 Anti-EGFR antibodies and antibody drug conjugates
Patent 10098968 was granted and assigned to AbbVie Inc. on October, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10098968 Anti-EGFR antibodies and antibody drug conjugates
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
